Al­ladapt touts da­ta on food al­ler­gy drug as it preps for PhI­II

Al­ladapt Im­munother­a­peu­tics said its food al­ler­gy drug helped chil­dren con­sume more of what they’re al­ler­gic to in a clin­i­cal tri­al, ac­cord­ing to re­sults pre­sent­ed on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER